Price $26.88 |
Market Cap
2.04B
|
Sector Health Care |
Div. Growth
-87.90%
|
|
P/E
50.2
|
P/B
3.64
|
P/S
0.21
|
Dividend %
-
|
|
P/CF
14.4
|
P/FCF
6.1
|
Op. Cash Flow
295.2K
|
FCF
4.4
|
|
Op. Margin
1.60%
|
Net Margin
-0.80%
|
ROE
-13.90%
|
ROI
4.10%
|
|
ROA
-1.70%
|
EPS Growth
79.30%
|
Current Ratio
1.7
|
Debt/Equity
326.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $12.32 | - | - | 10.6B | Strong Buy |
| IntriCon Corporation (IIN) | $20.62 | - | - | 162.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.62 | - | - | 166.4M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.75 | - | - | 77.3M | Strong Buy |
| Dynatronics Corporation (DYNT) | $1.25 | - | - | 12.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
